Browse Drug Recalls

6,348 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 6,348 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 6,348 FDA drug recalls.

Clear
DateProductReasonClassFirm
Mar 20, 2013 Diazepam 5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road,... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Medroxyprogesterone 150 mg/ml,Clinical Specialties Compounding Pharmacy, 318 ... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Methionine/Choline/Inositol/ B-12, Clinical Specialties Compounding Pharmacy,... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Latanoprost 0.025% eye drop, Clinical Specialties Compounding Pharmacy, 318 B... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Estradiol Valerate 30 mg/ml, Clinical Specialties Compounding Pharmacy, 318 B... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Estradiol Cypionate 5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 B... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Hydroxyprogesterone 250 mg/ml, Clinical Specialties Compounding Pharmacy, 318... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Pap 300 mg-phent 10 mg-prost 100 mcg, Clinical Specialties Compounding Pharma... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Acetylcysteine 20 % solution, 100 ml bottle, Clinical Specialties Compounding... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Test cyp 25 mg-estradiol cyp 7 mg/ml, Clinical Specialties Compounding Pharma... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Test Cyp 10 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Test Cyp 100 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Roa... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Test Cyp 200 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Roa... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Laser ophthalmic drops, 12 mL bottle, Clinical Specialties Compounding Pharma... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Cataract drops, Clinical Specialties Compounding Pharmacy, 318 Baston Road, A... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Cyclosporine 2% ophthalmic, Clinical Specialties Compounding Pharmacy, 318 Ba... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Test cyp 25 mg-Estadiol valerate 15 mg/mL, Clinical Specialties Compounding P... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Test cyp 75 mg-estradiol cyp 5 mg/ml, Clinical Specialties Compounding Pharma... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Cyclosporine 1% ophthalmic drops, Clinical Specialties Compounding Pharmacy, ... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 HCG 1000 units/ml, 30 mL syringe, Clinical Specialties Compounding Pharmacy, ... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Test cyp 50 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 HCG 500 units/ml, 10 mL syringe, Clinical Specialties Compounding Pharmacy, 3... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Test cyp 25 mg-Estradiol cyp 5 mg/ml, Clinical Specialties Compounding Pharma... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Test Cyp 50 mg-estradiol cyp 2 mg/ml, Clinical Specialties Compounding Pharma... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Test Cyp 250 mg-lidocaine 5 mg/ml, Clinical Specialties Compounding Pharmacy,... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Itraconazole 1% eye ointment, Clinical Specialties Compounding Pharmacy, 318 ... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 HCG 2000 units/ml, 30 mL syringe, Clinical Specialties Compounding Pharmacy, ... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Test Cyp 50 mg-estradiol cyp 2 mg/ml, Clinical Specialties Compounding Pharma... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 20, 2013 Test cyp 35 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... Class II Clinical Specialties Compounding Pharmacy
Mar 14, 2013 Magnesium Sulfate 2 grams in Dextrose 5% for Injection, in 50 mL Plastic Infu... Non-Sterility; mold contamination Class I Med Prep Consulting, Inc.
Mar 14, 2013 All Compounded Products, packaged in plastic infusion bags, devices, syringes... Lack of Assurance of Sterility; potential for mold contamination Class II Med Prep Consulting, Inc.
Mar 11, 2013 Avastin, (0.05 ml, 1.25 mg/0.05ml), single unit dose syringes, Clinical Speci... Lack of Assurance of Sterility; product linked to adverse event reports of endophthalimitis eye i... Class II Clinical Specialties Compounding Pharmacy
Mar 4, 2013 SEPP 10% Povidone Iodine Solution USP (1% available Iodine, Surfactant & USP ... Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile... Class II CareFusion 213, LLC
Mar 4, 2013 Donor Prep Kit containing 1 FREPP (70% isopropyl alcohol), Net 1.1 mL and 1 S... Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile... Class II CareFusion 213, LLC
Mar 4, 2013 SEPP 70% Isopropanol (isopropyl alcohol) 70% v/v, USP, 200-count applicators ... Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile... Class II CareFusion 213, LLC
Mar 4, 2013 FREPP/SEPP Kit containing 1 FREPP (povidone iodine 2% aqueous solution), Net ... Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile... Class II CareFusion 213, LLC
Mar 4, 2013 SEPP 2% Iodine Tincture USP (47% v/v Ethyl Alcohol, 2% w/v Iodine, USP, Sodiu... Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile... Class II CareFusion 213, LLC
Mar 4, 2013 Blood Culture Prep Kit II containing 1 FREPP (70% isopropyl alcohol), Net 1.1... Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile... Class II CareFusion 213, LLC
Feb 26, 2013 Diazepam Injection, USP 5 mg/mL, 10 mL, Multiple-dose fliptop vial, RX only, ... Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial. Class II Hospira Inc.
Feb 26, 2013 Furosemide Injection, USP, 40 mg/4mL (10 mg/mL), 4 ml Single-Dose Vial, Rx on... Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial. Class II Hospira Inc.
Feb 26, 2013 QUELICIN (succinylcholine chloride) Injection, USP, 200 mg (20 mg/mL) 10 mL, ... Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial. Class II Hospira Inc.
Feb 26, 2013 Sodium Acetate Injection, USP, 40 mEq/20 ml (2 mEq/mL) 20 mL Single-Dose Flip... Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial. Class II Hospira Inc.
Feb 18, 2013 0.9% Sodium Chloride Injection, USP, 50 mL, Manufactured by Hospira, Inc., La... Lack of Assurance of Sterility: The product is being recall due to the product lot being incorrec... Class II Hospira Inc.
Feb 15, 2013 METRONIDazole Injection, USP 500 mg (5 mg/mL), 100 mL Bag, Rx only, Hospira,... Lack of Assurance of Sterility: There is the potential for the solution to leak from the administ... Class II Hospira Inc.
Feb 12, 2013 0.9% Sodium Chloride Irrigation, USP, 3000 mL, Sterile, Non pyrogenic, Rx Onl... Lack of Assurance of Sterility: There is a potential for the solution to leak from the administra... Class II Hospira Inc.
Jan 25, 2013 Lactated Ringer's and 5% Dextrose Injection, USP, 1000 mL flexible container,... Non-Sterility: Confirmed customer complaint of product contaminated with mold. Class I Hospira Inc.
Jan 10, 2013 Furosemide Injection USP (10 mg/mL), 4 mL in 5 mL Fliptop Vial, Rx only, Hosp... Lack of Assurance of Sterility; possible loose crimp applied to fliptop vial Class II Hospira, Inc.
Jan 8, 2013 0.9% Sodium Chloride Injection USP, 100 mL Hospira, Inc., Lake Forest, IL 6... Lack of Assurance of Sterility: There is the potential for solution to leak from the administrati... Class II Hospira Inc.
Jan 3, 2013 Mitosol (mitomycin for solution), 0.2 mg/vial, Kit for Ophthalmic Use (NDC 49... Non-Sterility: one or more components of the kit have been found to be contaminated with yeast. Class I Mobius Therapeutics LLC
Dec 4, 2012 Cyanocobalamin 1000 mcg/ml, injection 30 mL, MDV, For Office Use Only, Green ... Non-Sterility: Green Valley Drugs received positive sterility results from their testing lab on t... Class I Green Valley Drugs

Frequently Asked Questions

When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.